Published in J Gen Virol on March 01, 1992
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
A distinct picornavirus group identified by sequence analysis. Proc Natl Acad Sci U S A (1992) 3.28
Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol (1995) 2.66
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J Virol (1994) 2.27
Analysis of a new human parechovirus allows the definition of parechovirus types and the identification of RNA structural domains. J Virol (2006) 1.87
Parechoviruses. J Virol (1999) 1.66
Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry. J Virol (2001) 1.46
The coxsackievirus A9 RGD motif is not essential for virus viability. J Virol (1995) 1.20
An evolutionarily conserved splice generates a secreted env-Bet fusion protein during human foamy virus infection. J Virol (1998) 1.19
Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9. J Virol (2004) 1.16
Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors. J Virol (2000) 1.16
Virus receptors: implications for pathogenesis and the design of antiviral agents. Clin Microbiol Rev (1995) 1.07
RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells. J Virol (2001) 1.06
Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D. J Virol (2008) 0.99
Symmetry-related clustering of positive charges is a common mechanism for heparan sulfate binding in enteroviruses. J Virol (2012) 0.94
Human parechovirus genotypes -10, -13 and -15 in Pakistani children with acute dehydrating gastroenteritis. PLoS One (2013) 0.79
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01
Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science (1996) 5.44
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum (1993) 5.05
Non-alcoholic steatohepatitis: another disease of affluence. Lancet (1999) 4.28
The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98
The complete nucleotide sequence of a common cold virus: human rhinovirus 14. Nucleic Acids Res (1984) 3.85
A highly conserved repeated DNA element located in the chromosome of Streptococcus pneumoniae. Nucleic Acids Res (1992) 3.73
Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64
Acquired immunodeficiency syndrome in New York City. Evaluation of an active surveillance system. JAMA (1985) 3.45
A distinct picornavirus group identified by sequence analysis. Proc Natl Acad Sci U S A (1992) 3.28
Viruses and bacteria in the etiology of the common cold. J Clin Microbiol (1998) 3.24
Is phimosis overdiagnosed in boys and are too many circumcisions performed in consequence? Ann R Coll Surg Engl (1989) 3.23
Worthing physiological scoring system: derivation and validation of a physiological early-warning system for medical admissions. An observational, population-based single-centre study. Br J Anaesth (2007) 2.98
Evidence of recombination among enteroviruses. J Virol (1999) 2.92
Traditional plant medicines as treatments for diabetes. Diabetes Care (1989) 2.91
Women prefer hospital births. BMJ (1992) 2.88
Detection and differentiation of picornaviruses in clinical samples following genomic amplification. J Gen Virol (1990) 2.77
Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia (1990) 2.75
Interpreting hospital mortality data. The role of clinical risk adjustment. JAMA (1989) 2.53
The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification. J Gen Virol (1989) 2.52
Detection of enteroviruses by spot hybridization. J Clin Microbiol (1984) 2.51
Amplification of rhinovirus specific nucleic acids from clinical samples using the polymerase chain reaction. J Med Virol (1989) 2.47
Genetic and phylogenetic clustering of enteroviruses. J Gen Virol (1996) 2.31
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab (2003) 2.29
Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J Virol (1994) 2.27
Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care (1998) 2.25
Human parechoviruses--biology and clinical significance. Rev Med Virol (2000) 2.24
Bacteriophytochromes are photochromic histidine kinases using a biliverdin chromophore. Nature (2001) 2.22
HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes (2001) 2.18
Classification of enteroviruses based on molecular and biological properties. J Gen Virol (1997) 2.16
Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology (1994) 2.13
Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization. J Clin Microbiol (1995) 2.10
Increasing the rate of chromatin remodeling and gene activation--a novel role for the histone acetyltransferase Gcn5. EMBO J (2001) 2.04
Increasing prevalence of obesity in primary school children: cohort study. BMJ (2001) 2.04
The Wessex Growth Study: first report. Acta Paediatr Scand Suppl (1989) 2.02
Molecular comparison of coxsackie A virus serotypes. Virology (1995) 2.00
The 2A proteins of three diverse picornaviruses are related to each other and to the H-rev107 family of proteins involved in the control of cell proliferation. J Gen Virol (2000) 1.96
Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology (1994) 1.96
Where next for prophylaxis against pre-eclampsia? Br J Obstet Gynaecol (1996) 1.95
Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr (1992) 1.95
Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types. Hum Pathol (1988) 1.95
Parechoviruses, a novel group of human picornaviruses. Ann Med (2001) 1.92
RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J Virol (1991) 1.91
Studies on the Toxemia Syndrome After Burns II: Central Nervous System Changes as a Cause of Death. Ann Surg (1945) 1.89
Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg (2005) 1.89
Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. Health Technol Assess (2001) 1.87
Molecular analysis of human parechovirus type 2 (formerly echovirus 23). J Gen Virol (1998) 1.84
Diagnosis and epidemiology of echovirus 22 infections. Clin Infect Dis (1998) 1.74
Predicting length of stay, functional outcome, and aftercare in the rehabilitation of stroke patients. The dominant role of higher-order cognition. Stroke (1993) 1.73
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res (1984) 1.71
The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol (1975) 1.71
The complete nucleotide sequence of coxsackievirus A21. J Gen Virol (1989) 1.70
Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science (1992) 1.69
An RNA tertiary structure in the 3' untranslated region of enteroviruses is necessary for efficient replication. J Virol (1997) 1.67
The relationship between beliefs about nutrition and dietary practices of the elderly. J Am Diet Assoc (1990) 1.67
The major echovirus group is genetically coherent and related to coxsackie B viruses. J Gen Virol (1996) 1.67
The nucleotide sequence of human rhinovirus 1B: molecular relationships within the rhinovirus genus. J Gen Virol (1988) 1.67
Parechoviruses. J Virol (1999) 1.66
Issues of recruitment, retention, and compliance in community-based clinical trials with traditionally underserved populations. Appl Nurs Res (1995) 1.65
Identification of enteroviruses in clinical specimens by competitive PCR followed by genetic typing using sequence analysis. J Clin Microbiol (1996) 1.64
Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun (1989) 1.64
Effect of preoperative anaesthetic visit on anxiety. Br Med J (1977) 1.64
Colorectal carcinoma in children and adolescents--a report of seven cases. Eur J Pediatr Surg (2001) 1.64
Diagnosis of malaria in a remote area of the Philippines: comparison of techniques and their acceptance by health workers and the community. Bull World Health Organ (2001) 1.63
Polymerase chain reaction amplification of rhinovirus nucleic acids from clinical material. Nucleic Acids Res (1988) 1.63
An assessment of the accuracy of clinical diagnosis, local microscopy and a rapid immunochromatographic card test in comparison with expert microscopy in the diagnosis of malaria in rural Kenya. Trans R Soc Trop Med Hyg (2000) 1.62
Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes. Mol Biochem Parasitol (2000) 1.62
Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group. Diabetes Care (1993) 1.60
Detection of Chlamydia trachomatis in clinical specimens by nucleic acid spot hybridization. J Gen Microbiol (1985) 1.59
Rectal examination in paediatric surgical practice. Br J Surg (1999) 1.58
Rapid discrimination between methicillin-sensitive and methicillin-resistant Staphylococcus aureus by intact cell mass spectrometry. J Med Microbiol (2000) 1.57
Human health implications of environmental contaminants in Arctic Canada: a review. Sci Total Environ (1999) 1.57
Relief from chronic pain by low power laser irradiation. Neurosci Lett (1983) 1.56
Germline mutation of the tumour suppressor PTEN in Proteus syndrome. J Med Genet (2002) 1.50
Molecular relationships between 21 human rhinovirus serotypes. J Gen Virol (1995) 1.50
Outcomes after localized axillary node recurrence in breast cancer. Ann Surg Oncol (2003) 1.47
Obstacles to timely neonatal screening in North Thames. J Med Screen (1998) 1.47
Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with a standard regimen. Hum Reprod (2012) 1.46
Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry. J Virol (2001) 1.46
Molecular epidemiology and evolution of coxsackievirus A9. J Gen Virol (2000) 1.44
Poliovirus type 3: molecular cloning of the genome and nucleotide sequence of the region encoding the protease and polymerase proteins. Nucleic Acids Res (1983) 1.43
The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses. Structure (1999) 1.43
Schistosomiasis in Australian travellers to Africa. Med J Aust (1997) 1.43
An interstate drowning study. Am J Public Health Nations Health (1968) 1.42
The role of the practice nurse in the management of depression in general practice: treatment adherence to antidepressant medication. Psychol Med (1993) 1.41
K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification. Clin Chem (2000) 1.40
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia (2007) 1.40
Entry of human parechovirus 1. J Virol (2001) 1.39
Induction for rapid sequence induction: a tri-deanery survey. Anaesthesia (2012) 1.39
Mutants of nonproducer cell lines transformed by murine sarcoma viruses. I. Induction, isolation, particle production, and tumorigenicity. J Exp Med (1973) 1.39
Homology of cryptic plasmid of Neisseria gonorrhoeae with plasmids from Neisseria meningitidis and Neisseria lactamica. J Clin Pathol (1986) 1.38
Construction of poliovirus intertypic recombinants by use of cDNA. J Virol (1986) 1.38